Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Frédérique Spyratos"'
Autor:
John W.M. Martens, Ralf Lesche, John A. Foekens, Stephan Niemann, Achim Plum, Sabine Maier, Katrin Welzel, Florence Lerebours, Vincent Vuaroqueaux, Serenella Eppenberger-Castori, Manfred Schmitt, Anne Fassbender, Dimo Dietrich, Nadia Harbeck, Frédérique Spyratos, Oliver Hartmann
Supplementary Data from DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7534fcc82e3902419c527b954ef8249
https://doi.org/10.1158/1078-0432.22439427
https://doi.org/10.1158/1078-0432.22439427
Autor:
Jacqueline Lehmann-Che, Ivan Bièche, Bernard Asselain, Anne-Sophie Hamy, J.-M. Guinebretiere, Brigitte Sigal-Zafrani, Frédérique Spyratos, Ph. Bertheau, Michel Marty, M. C. Matthieu, Véronique Scott, P. de Cremoux, O Tembo
Publikováno v:
Breast Cancer Research and Treatment. 159:499-511
Neoadjuvant systemic therapy (NAC) is currently used in the treatment of stage II/III breast cancer. Pathological complete response as a surrogate endpoint for clinical outcomes is not completely validated for all subgroups of breast cancers. Therefo
Autor:
Sylvie Giacchetti, Jacqueline Lehmann-Che, Ivan Bièche, Jean Marc Guinebretière, Philippe Bertheau, Bernard Asselain, Frédérique Spyratos, Patricia de Cremoux, Marie-Christine Mathieu, Jean-Yves Pierga, Véronique Scott, Michel Marty, Anne-Sophie Hamy, B Sigal, Etienne Brain
Publikováno v:
Anticancer Research. 38
BACKGROUND The prognostic and predictive role of cyclo-oxygenase-2 (COX2) in breast cancer is still debated, and in particular, its role as a target of COX2 inhibitor (celecoxib) in neoadjuvant setting. MATERIALS AND METHODS We analyzed a series of 1
Autor:
Géraldine Cizeron-Clairac, Sophie Vacher, C. Bélichard, Jean-Louis Alberini, Etienne Brain, Rosette Lidereau, Frédérique Spyratos, Emmanuelle Mouret-Fourme, Aurélie Susini, Florence Lerebours, Ivan Bièche
Publikováno v:
International Journal of Cancer. 133:1614-1623
IBC (inflammatory breast cancer) is a rare but very aggressive form of breast cancer with a particular phenotype. The molecular mechanisms responsible for IBC remain largely unknown. In particular, genetic and epigenetic alterations specific to IBC r
Autor:
Véronique Scott, O Tembo, Jacqueline Lehmann-Che, Ivan Bièche, Michel Marty, Patricia de Cremoux, Bernard Asselain, Frédérique Spyratos, Fabien Valet
Publikováno v:
Breast Cancer Research and Treatment. 134:443-448
In addition to their major interest in refining disease classifications and improving diagnostic and prognostic accuracy by means of molecular signatures, microarrays have been proposed in breast cancer as an alternative to routine immunohistochemist
Autor:
Pascal Bonnier, Chafika Mazouni, Sylvie Romain, P M Martin, Frédéric Fina, L.’H. Ouafik, Frédérique Spyratos
Publikováno v:
Cancer Research. 71:P4-09
Background: Currently, the usefulness of conventional markers for breast carcinoma is limited to assess individual outcome. A statistical model was developed to improve the prognostic accuracy using multiple conventional and emerging prognostic bioma
Autor:
Frédérique Spyratos, Margaret Haugh, Alain Fourquet, Anne Gompel, Hubert Crouet, Bruno Poulet, Caroline Egele, Etienne Brain, Marc Spielmann, Jocelyne Jacquemier, Nicole Tubiana-Mathieu, Pierre-Marie Martin, Patricia de Cremoux, Brigitte Sigal-Zafrani, Frédérique Penault-Llorca, Nicolas Rouyer, Marie-Pierre Chenard, Jean-Pierre Lefranc, Elisabeth Luporsi, Laurent Arnould, Fabrice Andre, Krishna B. Clough, Carole Mathelin, Daniel Serin, Jean-Pierre Bellocq
Publikováno v:
Breast Cancer Research and Treatment
Clinicians can use biomarkers to guide therapeutic decisions in estrogen receptor positive (ER+) breast cancer. One such biomarker is cellular proliferation as evaluated by Ki-67. This biomarker has been extensively studied and is easily assayed by h
Autor:
Emmanuelle Menet, Véronique Becette, Michèle Tubiana-Hulin, Frédérique Spyratos, M. Briffod, Florence Lerebours
Publikováno v:
The Breast Journal. 17:121-128
Neo-adjuvant chemotherapy of breast cancer provides an opportunity to evaluate predictive factors at initial tumor biopsy. We evaluated these factors on cell blocks obtained by diagnostic fine-needle cytopuncture (FNC), with respect to tumor regressi
Autor:
Bo Nordenskjöld, Barbro Linderholm, Betzabe Chavez Sanchez, Frédérique Spyratos, Helena Fohlin, Olle Stål, Marie Sundqvist
Publikováno v:
European Journal of Cancer. 46:1580-1587
Previous retrospective studies have shown that high intratumoural levels of vascular endothelial growth factor (VEGF) correlate with an inferior outcome for patients treated with adjuvant tamoxifen. Our objectives were to validate the impact of VEGF
Autor:
Yves Caron, Diana Kassab-Chahmi, Valérie Mazeau-Woynar, Lise Bosquet, Fabrice Andre, Jean-Pierre Bellocq, Henri Roché, Brigitte Sigal-Zafrani, Rémy Salmon, Elisabeth Luporsi, Anne Gompel, Pierre Fumoleau, Pierre-Marie Martin, Frédérique Spyratos
Publikováno v:
Oncologie. 12:158-163